Oncology Brothers

@oncbrothers.bsky.social

1 year ago

#Encorafenib + #Ceruximab + mFOLFOX is approved in 1L for BRAFV600e based off #BREAKWATER

- ORR 61% vs 40%
- mDoR: 13.9mos vs 11.1mos
- AEs:GI tox, rash

#cansky #oncsky #gism